Skip to search formSkip to main contentSkip to account menu

technetium Tc 99m-nofetumomab merpentan

Known as: Nofetumomab, Tc 99m NR-LU-10, technetium Tc 99m-nofetumomab merpentan [Chemical/Ingredient] 
National Institutes of Health

Related topics

Related topics

6 relations
Diagnostic agentsDrug AllergyHuman B-Lymphocyte Antigen CD20, human

Broader (2)

Monoclonal AntibodiesOrganotechnetium Compounds

Narrower (1)

Verluma

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Radioimmunodetection of Cancer
Radiolabeled monoclonal antibodies have gained widespread acceptance as relatively receptor-specific radiopharmaceuticals for… 
2000
2000
Tc-99m nofetumomab merpentan complements an equivocal bone scan for detecting skeletal metastatic disease from lung cancer.
A 56-year-old man with recently diagnosed mixed small-cell and non-small-cell lung carcinoma of the left lung apex was referred… 
1997
1997
Clinical experience with Tc-99m nofetumomab merpentan (Verluma) radioimmunoscintigraphy.
Tc-99m nofetumomab merpentan (Verluma), consisting of a Fab fragment of the pancarcinoma murine antibody NR-LU-10, has been… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)